Ventricular Dysfunction
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
BioCardiaCA - Sunnyvale
1 program1
Transendocaridal Transplantation of Autologous Bone MarrowPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BioCardiaTransendocaridal Transplantation of Autologous Bone Marrow
Berlin HeartEXCOR Pediatric
AbbottApical pacing
Clinical Trials (3)
Total enrollment: 135 patients across 3 trials
Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone
Start: Dec 2005Est. completion: Aug 200920 patients
Phase 1Completed
Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
Start: Oct 2018Est. completion: May 202262 patients
N/AUnknown
Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI
Start: Feb 2012Est. completion: Dec 201553 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.